DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

DexCom, Inc. DXCM recently announced the FDA clearance for its 15-day wear G7 Continuous Glucose Monitoring (CGM) system, the ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

A team of medical researchers and engineers at RSP Systems, in Denmark, working with a pair of colleagues from the Institute ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

Ex-Intel head says TSMC’s new investment will not resurrect US chip sector Read the Market Summary Here:- Global Blood Glucose Monitoring System Market is valued at approximately USD 16.46 billion in ...